Osteomark

Osteomark®

Metabolism A proprietary urine test for measuring bone loss, quantifying cross-linked N-telopeptides–NTx, which are degradation products of bone resorption and are unique biochemical markers specific for the type I collagen–found in bone. See Hormone replacement therapy, N-telopeptides, Osteoporosis.
References in periodicals archive ?
A group of researchers compared the Pyrilinks-D test to other bone resorption tests like Osteomark and CrossLaps.
27 healing Secrets your doctor doesn't know: you'll love the side effect of this radical weight loss solution
A urine test developed by OSTEOMARK can determine whether a woman's body is losing bone density.
Old Bones in Young Bodies
sALP was determined by the Tandem-MP Ostase Immunoenzymetric Assay (Beckman Coulter) (10) and NTx by the Osteomark NTx Assay (Ostex International) (11).
Osteoprotegerin in serum as a novel marker of bone metastatic spread in prostate cancer
Urine Ntx was measured by the Osteomark immunoassay (Ostex) (5).
Diurnal variations in serum and urine markers of type I and type III collagen turnover in children
Urinary NTx was quantified with the Osteomark immunoassay kit.
Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption
NTx were measured with Osteomark (Ostex International) [21].
Comparison of analytical performance and biological variability of three bone resorption assays
Medical browser ?
Full browser ?